Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06351358 · ClinicalTrials.gov registry record · NA

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

A NA study of Weight Loss and Photoaging, sponsored by Galderma R&D.

Active
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06351358 is a NA study of Weight Loss and Photoaging that is active but no longer recruiting, run by Galderma R&D. The registered enrollment target is 40 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06351358, a NA study of Weight Loss and Photoaging, is active but no longer recruiting, sponsored by Galderma R&D.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

Adult subjects with a history of or currently taking glucagon-like peptide-1 (GLP-1) receptor agonist medication and moderate-to-severe cheek wrinkles and midface contour deficiencies will be treated with Sculptra correction of fine lines and wrinkles in the cheek area and Restylane Lyft or Restylane Contour for cheek augmentation and correction of midface contour deficiencies.

Conditions Studied

Weight Loss Photoaging Skin Laxity Photodamaged Skin Volume Deficiency of the Midface

Interventions

  • DEVICE Sculptra treatment
  • DEVICE Restylane Treatment

Study Locations (2)

District of Columbia

  • Somenek + Pittman MD: Advanced Plastic Surgery - Washington D.C.

New York

  • Lorenc Aesthetic Plastic Surgery Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-19
Est. Completion 2025-05-31
Phase NA

Sponsor

Galderma R&D

158 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06351358

The ClinicalTrials.gov registry entry for NCT06351358 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Sculptra treatment is the first listed.

NCT06351358 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, New York.

Frequently Asked Questions

What is clinical trial NCT06351358 about?

NCT06351358 is a clinical study titled "Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies". Adult subjects with a history of or currently taking glucagon-like peptide-1 (GLP-1) receptor agonist medication and moderate-to-severe cheek wrinkles and midface contour deficiencies will be treated with Sculptra correction of fine lines and wrinkles in the cheek area and Restylane Lyft or Restylan...

What is the current status of trial NCT06351358?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-19. Estimated completion is 2025-05-31.

What conditions does trial NCT06351358 study?

This clinical trial studies the following conditions: Weight Loss, Photoaging, Skin Laxity, Photodamaged Skin, Volume Deficiency of the Midface.

What interventions are being tested in trial NCT06351358?

The interventions under investigation include: Sculptra treatment (DEVICE), Restylane Treatment (DEVICE).

Who is sponsoring clinical trial NCT06351358?

This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06351358 being conducted?

This trial has 2 study locations across District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Weight Loss

All registered trials for this condition

Photoaging

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.